TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.” July 7, 1995
TCL Archive DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts November 9, 1979
